Prevalence and risk factors of sarcopenia in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Authors:
Open Access
- 8 June 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1187760
Abstract
Background: Sarcopenia often occurs as a comorbidity in many diseases which ultimately affects patient prognosis. However, it has received little attention in patients with idiopathic pulmonary fibrosis (IPF). This systematic review and meta-analysis aimed at determining the prevalence and risk factors of sarcopenia in patients with IPF.Methods: Embase, MEDLINE, Web of Science, and Cochrane databases were searched using relevant MeSH terms until December 31, 2022. The Newcastle-Ottawa Scale (NOS) was used for quality assessment and data analysis were performed using Stata MP 17.0 (Texas, USA). A random effects model was adopted to account for differences between articles, and the I2 statistic was used to describe statistical heterogeneities. Overall pooled estimates obtained from a random effects model were estimated using the metan command. Forest plots were generated to graphically represent the data of the meta-analysis. Meta-regression analysis was used for count or continuous variables. Egger test was used to evaluate publication bias and, if publication bias was observed, the trim and fill method was used.Main results: The search results showed 154 studies, and five studies (three cross-section and two cohort studies) with 477 participants were finally included. No significant heterogeneity was observed among studies included in the meta-analysis (I2 = 16.00%) and our study's publication bias is low (Egger test, p = 0.266). The prevalence of sarcopenia in patients with IPF was 26% (95% CI, 0.22–0.31). The risk factors for sarcopenia in patients with IPF were age (p = 0.0131), BMI (p = 0.001), FVC% (p < 0.001), FEV1% (p = 0.006), DLco% (p ≤ 0.001), and GAP score (p = 0.003).Conclusions: The pooled prevalence of sarcopenia in patients with IPF was 26%. The risk factors for sarcopenia in IPF patients were age, BMI, FVC%, FEV1%, DLco%, and GAP score. It is important to identify these risk factors as early as possible to improve the life quality of patients with IPF.Keywords
This publication has 36 references indexed in Scilit:
- Building strength, endurance, and mobility using an astaxanthin formulation with functional training in elderlyJournal of Cachexia, Sarcopenia and Muscle, 2018
- Idiopathic pulmonary fibrosisNature Reviews Disease Primers, 2017
- Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort studyRespiratory Research, 2016
- Nutrition in chronic obstructive pulmonary disease: A reviewJournal of Translational Internal Medicine, 2015
- Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled TrialJournal of the American Medical Directors Association, 2015
- More attention to comprehensive assessment and individualized therapy of chronic obstructive pulmonary diseaseJournal of Translational Internal Medicine, 2015
- Muscle wasting in disease: molecular mechanisms and promising therapiesNature Reviews Drug Discovery, 2014
- Skeletal muscle atrophy during short-term disuse: Implications for age-related sarcopeniaAgeing Research Reviews, 2013
- Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐AnalysisBiometrics, 2000
- Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus StatementAmerican Journal of Respiratory and Critical Care Medicine, 2000